Azitra, Inc. (AZTR)
Data as of , from SEC Form 4 filings.
See up to 3 months of AZTR. The 7-day demo opens the 1M and 3M ranges and puts AZTR on your watchlist.
Start 7-day demoLatest AZTR insider trades
About Azitra, Inc. (AZTR)
Azitra, Inc. is an SEC registrant, filing under CIK 0001701478, classified as pharmaceutical preparations. We track it alongside the rest of the Health Care sector. A registration statement was filed on 10 December 2025. No offering has priced.
AZTR Form 4 activity by transaction type, last 90 days
No Form 4 activity for AZTR in the last 90 days.
AZTR insider transactions (Form 4)
1310 Form 4 filings on record, the earliest from Dec 22, 2025, newest first.
| Traded | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Francisco D. Salva - Officer | Other | Common Stock | 4,064,050 | - footnote F1 | - | |
| Francisco D. Salva - Officer | Other | Series A Convertible Non-Redeemable Preferred Stock | 500 | - footnote F1 | - | |
| ||||||
| Norm Staskey - Officer | Grant or award | Stock Options (Right To Buy) | 35,524 | $0.00 | - | |
| Francisco D. Salva - Officer | Grant or award | Stock Options (Right To Buy) | 220,879 | $0.00 | - | |
| Travis Whitfill - Officer | Grant or award | Stock Options (Right To Buy) | 64,300 | $0.00 | - | |
| Francisco D. Salva - Officer | Open-market purchase | Series A Convertible Non-Redeemable Preferred Stock | 500 | - footnote F1 | - | |
| Francisco D. Salva - Officer | Open-market purchase | Series B Warrants | 4,064,050 | - footnote F1 | - | |
| Francisco D. Salva - Officer | Open-market purchase | Series C Warrants | 4,064,050 | - footnote F3 | - | |
| ||||||
| Travis Whitfill - Officer | Grant or award | Stock Options (Right To Buy) | 23,724 | $0.00 | - | |
| Francisco D. Salva - Officer | Grant or award | Stock Options (Right To Buy) | 59,309 | $0.00 | - | |
| Barbara Ryan - Director | Grant or award | Stock Options (Right To Buy) | 3,003 | $0.00 | - | |
| Norm Staskey - Officer | Grant or award | Stock Options (Right To Buy) | 15,015 | $0.00 | - | |
| John R. Schroer - Director | Grant or award | Stock Options (Right To Buy) | 3,003 | $0.00 | - | |
AZTR insider trading FAQ
What is the latest insider trade for AZTR?
Azitra, Inc. (AZTR) has filed no insider reports in the last 90 days. The most recent on record is dated 18 June 2026. The full record for AZTR runs to 10 Form 4 filings, the earliest from 22 December 2025. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying AZTR stock?
No insider purchases of AZTR were filed in the last 90 days. 3 purchases are on record for this company.
How many insiders are selling AZTR stock?
No insider sales of AZTR were filed in the last 90 days.
Where can I see AZTR SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects AZTR Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Francisco D. Salva view on EDGAR
- - Norm Staskey view on EDGAR
- - Francisco D. Salva view on EDGAR
- - Travis Whitfill view on EDGAR
- - Francisco D. Salva view on EDGAR
- - Travis Whitfill view on EDGAR
- - Francisco D. Salva view on EDGAR
- - Barbara Ryan view on EDGAR
- - Norm Staskey view on EDGAR
- - John R. Schroer
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where AZTR's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow AZTR with a 7-day demo
- AZTR on your watchlist
- Every AZTR Form 4 filing on record
- Up to 3 months of AZTR price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
